ClearPoint Neuro (CLPT) EBITDA Margin (2011 - 2026)
ClearPoint Neuro (CLPT) posted EBITDA Margin of 69.9% for Q1 2026, down 3.29% sequentially from 67.68% in Q4 2025, and up 273.0% YoY from 18.74% in Q1 2025.
ClearPoint Neuro (CLPT) EBITDA Margin (2011 - 2026) Analysis & Trends
ClearPoint Neuro has reported EBITDA Margin for 15 years, with the latest figure at 69.9% in Q1 2026.
- Quarterly EBITDA Margin rose 273.0% year-over-year to 69.9% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 65.2% (up 206.0% YoY) and the FY2025 annual result came in at 65.36%, down 249.0% from the prior year.
- EBITDA Margin declined to 69.9% in Q1 2026 per CLPT's latest filing, from 67.68% in the prior quarter.
- Over five years, EBITDA Margin peaked at 55.19% in Q1 2024 and troughed at 119.85% in Q2 2023.
- A 5-year average of 75.27% and a median of 72.53% in 2024 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2023 and 2024: EBITDA Margin sank 3900 bps in 2023, then surged 5973 bps in 2024.
- Over 5 years, EBITDA Margin stood at 86.37% in 2022, then climbed by 20 bps to 69.1% in 2023, then declined by 5 bps to 72.53% in 2024, then advanced by 7 bps to 67.68% in 2025, then fell by 3 bps to 69.9% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 69.9%, 67.68%, and 59.54% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 19.15% |
| 10 | ClearPoint Neuro | 460.04 Mn | 430.64 Mn | 6.71 Mn | -94.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -94.15% |
| Mar 31, 2026 | -69.90% |
| Dec 31, 2025 | -67.68% |
| Sep 30, 2025 | -59.54% |
| Jun 30, 2025 | -61.64% |
| Mar 31, 2025 | -72.63% |
| Dec 31, 2024 | -72.53% |
| Sep 30, 2024 | -63.51% |
| Jun 30, 2024 | -60.12% |
| Mar 31, 2024 | -55.19% |
| Dec 31, 2023 | -69.10% |
| Sep 30, 2023 | -84.99% |
| Jun 30, 2023 | -119.85% |
| Mar 31, 2023 | -105.14% |
| Dec 31, 2022 | -86.37% |
| Sep 30, 2022 | -73.75% |
| Jun 30, 2022 | -80.85% |
| Mar 31, 2022 | -76.80% |
| Dec 31, 2021 | -92.99% |
| Sep 30, 2021 | -83.17% |